Skip to main content

UBS Group AG

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1610520 ZURICH, V8

Position in ADPT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
67,110
+18.8% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Derivatives in ADPT

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
715,530
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,492,966,338 across 42 Diagnostics & Research names. ADPT ranks #42 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADPT

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 2,862,120
2026-06-30 268,439
2026-03-31 225,986
2025-12-31 511,927
2025-09-30 253,980
2025-06-30 455,406
2025-03-31 275,617
2024-12-31 397,258
2024-09-30 73,151
2024-06-30 56,631
2024-03-31 143,615
2023-12-31 132,520
2023-09-30 90,318
2023-06-30 102,341
2023-03-31 86,858
2022-12-31 62,136
2022-09-30 27,005
2022-06-30 25,280
2022-03-31 49,652
2021-12-31 49,602
2021-09-30 52,058
2021-06-30 15,297
2021-03-31 21,981
2020-12-31 22,967
2020-09-30 26,678
2020-06-30 23,012
2020-03-31 26,718